20 parallel-processing-bioinformatics-"DIFFER" Fellowship positions at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
Category
-
Field
-
the Faculty of Life Sciences & Medicine Hub for Applied Bioinformatics. This post is jointly funded by the Borne Foundation (50%) and King’s Health Partner’s Centre for Translational Medicine (CTM) (50
-
the Medical Research Council. The Research Fellow will be using Natural Language Processing (NLP) methods, with a special focus on generative Large Language Models (LLMs), to interrogate a very large sample of
-
-quality teaching. The Hub for Applied Bioinformatics (HAB) is the Faculty’s focal point for computational biology, delivering bespoke bioinformatics support and training across genomics, transcriptomics
-
academics and researchers in the field, contributing to impactful studies aimed at enhancing the psychological care of patients across different health settings. About the role: This is an exciting
-
. We particularly value conversation between scholars of different periods and places, with different approaches. We also value our connections beyond the world of scholarship, with strong relationships
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
the role Overview of the role We are seeking a highly motivated Research Fellow in Machine Learning to join the PharosAI team, focusing on developing novel machine learning methods in computer vision
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
skills and ability to prioritise different task demands Knowledge of research design Eligible for UK PhD fees or evidence of how they can fund International PhD fees Excellent presentation and
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported